local analgesia in major gynecologic surgeries. Unspecified condition associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention 1: 10 to 12 mls of Bupivacain 0.125 together with 25 micrograms of Fentanyl will be injected via epidural catheter as a bolus dose, 20 minutes before the end of the surgery for individual
Prevention
10 to 12 mls of Bupivacain 0.125 together with 25 micrograms of Fentanyl will be injected via epidural catheter as a bolus dose, 20 minutes before the end of the surgery for individuals in the group p
10 to 12 mls of bupivacain 0.125 and 25 micrograms of fentanyl as a bolus dose, 20 minutes before the initiation of the surgery and bupivacain 0.125 with a rate of 2 ml per minute as a continuous infu
Sponsors
Tabriz Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 149 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (being over 18 years; having indication for major gynecologic surgery) Exclution criteria: (to have a contraindication for epidural analgesia; to have allergy to local anesthetics; to have mental disorders; organic dysfunctions; previous chronic pain)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: 0, 3, 6, 12 and 24 hours after becoming conscious. Method of measurement: using visual pain scoring (VAS) from 0 (without pain) to 10 (severe intolerable pain).;Analgesics administered dose. Timepoint: 0-3-6-12-24 hours after becoming conscious. Method of measurement: Injection count and injection dose in milli or micro grams. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSimin Atashkhoyi
Tabriz Medical University
Outcome results
None listed